Precigen Inc
PGEN
NASDAQ
Biotechnology
$6.10
USD
-0.39 (-6.01%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.33B
Volume 7.9M
Price Target
$18.00 – $18.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $18.00 and a min estimate of $18.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$18.00
+$7.0 vs prior
Implied Upside
+195.1%
+114.8% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Swayampakula Ramakanth | HC Wainwright & Co. | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AGIO
Agios Pharmaceuticals Inc
$33.56
▲ +0.3%
ADMA
ADMA Biologics Inc
$9.47
▲ +0.6%
ZBIO
Zenas Biopharma Inc
$29.51
▲ +1.1%
PVLA
Palvella Therapeutics Inc
$156.13
▼ -0.3%
STOK
Stoke Therapeutics Inc
$31.27
▼ -0.1%
MLYS
Mineralys Therapeutics Inc
$25.64
▼ -1.7%
VRDN
Viridian Therapeutics Inc
$22.08
▲ +0.4%
GENB
Generate Biomedicines Inc
$15.64
▲ +4.1%